NVOX Launches U.S. Clinical Network for ADHD Assessment

NVOX Inc., a U.S. healthcare technology company focused on clinician-integrated ADHD assessment, has launched its national clinical network for licensed professionals across the United States.

The launch follows more than 3.5 years of development and more than 1,000 completed assessments during NVOX's initial operating phase.

NVOX is designed to collect, organize and structure multiple sources of clinical and behavioral evidence before professional review, helping clinicians work from a more complete and organized case record.

Clinical interpretation and final conclusions remain with licensed professionals.

Addressing the Clinician-Time Bottleneck

One of the challenges facing ADHD assessment in the United States is not simply demand. It is clinician time.

A 2026 study of 1,520 U.S. clinicians found that only 46.0% offered ADHD diagnostic services for adults and 42.6% for children. Approximately four in ten clinicians involved in ADHD services or referrals cited lack of time to evaluate patients as a barrier.

NVOX is designed to reduce the operational burden surrounding assessment by bringing intake information, questionnaires, collateral input, assessment results, digital markers and structured report preparation into one clinical workflow.

The goal is not to replace clinicians. It is to allow more of their time to be spent on review, interpretation, patient interaction and professional judgment.

Source:
Newsome K, et al. Journal of the American Board of Family Medicine, 2026. DOI: 10.3122/jabfm.2025.250252R1

Two Ways Clinicians Can Work With NVOX

Approved clinicians can use the NVOX ADHD assessment platform with their own clients.

NVOX organizes the assessment process and case materials, while the clinician remains responsible for professional review and clinical conclusions.

There is no membership or platform fee for clinicians to join the NVOX Network.

NVOX Direct is a separate pathway for approved clinicians who want to review cases originating through NVOX.

NVOX Direct clinicians are compensated for the professional services they provide and can accept cases based on their availability.

A Clinician-Integrated Model

NVOX brings together clinical history, structured questionnaires, collateral information, objective assessment tasks, digital behavioral signals and organized reporting within a professional review workflow.

No individual questionnaire, task, behavioral signal or AI-supported output independently determines the result.

The platform is designed to support clinical judgment, not automate it.

NVOX introduced its clinical model to clinicians and other professionals at the American Psychological Association's 2026 convention in Washington, D.C. The U.S. clinical network is the company's next step in expanding access to the platform.

For Clinicians

Licensed clinicians interested in using NVOX with their own clients or applying to review NVOX Direct cases can learn more below.

About NVOX Inc.

NVOX Inc. is a clinician-integrated healthcare technology company focused on ADHD assessment. The NVOX platform organizes multiple sources of clinical and behavioral evidence into a structured assessment workflow for professional review.

More than 1,000 assessments were completed through NVOX during its initial operating phase.

NVOX is designed to support licensed clinicians while preserving professional responsibility for clinical interpretation and final conclusions.